301 related articles for article (PubMed ID: 27316506)
1. Role of cardiac MRI in nonischemic cardiomyopathies.
Anand S; Janardhanan R
Indian Heart J; 2016; 68(3):405-9. PubMed ID: 27316506
[TBL] [Abstract][Full Text] [Related]
2. Role of cardiac MRI in the assessment of nonischemic cardiomyopathies.
Kassi M; Nabi F
Methodist Debakey Cardiovasc J; 2013; 9(3):149-55. PubMed ID: 24066198
[TBL] [Abstract][Full Text] [Related]
3. Relationship of cardiac magnetic resonance imaging and myocardial biopsy in the evaluation of nonischemic cardiomyopathy.
Dickerson JA; Raman SV; Baker PM; Leier CV
Congest Heart Fail; 2013; 19(1):29-38. PubMed ID: 22963032
[TBL] [Abstract][Full Text] [Related]
4. Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.
Shehata ML; Turkbey EB; Vogel-Claussen J; Bluemke DA
Top Magn Reson Imaging; 2008 Feb; 19(1):43-57. PubMed ID: 18690160
[TBL] [Abstract][Full Text] [Related]
5. Cardiac MRI evaluation of nonischemic cardiomyopathies.
François CJ; Schiebler ML; Reeder SB
J Magn Reson Imaging; 2010 Mar; 31(3):518-30; quiz 517. PubMed ID: 20187194
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular magnetic resonance: contribution to the exploration of cardiomyopathies.
Schiau C; Schiau Ş; Dudea SM; Manole S
Med Pharm Rep; 2019 Oct; 92(4):326-336. PubMed ID: 31750431
[TBL] [Abstract][Full Text] [Related]
7. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
[TBL] [Abstract][Full Text] [Related]
8. When to Use Cardiovascular Magnetic Resonance in Patients with Heart Failure.
Rao RA; Jawaid O; Janish C; Raman SV
Heart Fail Clin; 2021 Jan; 17(1):1-8. PubMed ID: 33220878
[TBL] [Abstract][Full Text] [Related]
9. Correlation between extent of myocardial fibrosis assessed by cardiac magnetic resonance and cardiac troponin T release in patients with nonischemic heart failure.
Takashio S; Yamamuro M; Uemura T; Utsunomiya D; Morita K; Izumiya Y; Sugiyama S; Kojima S; Yamamoto E; Tsujita K; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Yasuda O; Yamashita Y; Ogawa H
Am J Cardiol; 2014 May; 113(10):1697-704. PubMed ID: 24698466
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis.
Fikrle M; Palecek T; Masek M; Kuchynka P; Straub J; Spicka I; Rysava R; Linhart A
Clin Physiol Funct Imaging; 2016 May; 36(3):218-24. PubMed ID: 25393773
[TBL] [Abstract][Full Text] [Related]
11. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
[TBL] [Abstract][Full Text] [Related]
12. Utility of combination of cardiac magnetic resonance imaging and high-sensitivity cardiac troponin T assay in diagnosis of inflammatory cardiomyopathy.
Šramko M; Kubánek M; Tintěra J; Kautznerová D; Weichet J; Malušková J; Franeková J; Kautzner J
Am J Cardiol; 2013 Jan; 111(2):258-64. PubMed ID: 23102878
[TBL] [Abstract][Full Text] [Related]
13. Cardiac magnetic resonance imaging for myocarditis and nonischemic cardiomyopathies.
Wassmuth R
Minerva Cardioangiol; 2009 Aug; 57(4):511-20. PubMed ID: 19763072
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies.
Parsai C; O'Hanlon R; Prasad SK; Mohiaddin RH
J Cardiovasc Magn Reson; 2012 Aug; 14(1):54. PubMed ID: 22857649
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Magnetic Resonance in Nonischemic Cardiomyopathies.
Yang EY; Shah DJ
Methodist Debakey Cardiovasc J; 2020; 16(2):97-105. PubMed ID: 32670469
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.
Karamitsos TD; Neubauer S
Curr Cardiol Rep; 2013 Jan; 15(1):326. PubMed ID: 23250662
[TBL] [Abstract][Full Text] [Related]
17. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.
Piers SR; Tao Q; de Riva Silva M; Siebelink HM; Schalij MJ; van der Geest RJ; Zeppenfeld K
JACC Cardiovasc Imaging; 2014 Aug; 7(8):774-84. PubMed ID: 25051947
[TBL] [Abstract][Full Text] [Related]
18. Cardiac magnetic resonance evaluation of left ventricular remodelling distribution in cardiac amyloidosis.
Pozo E; Kanwar A; Deochand R; Castellano JM; Naib T; Pazos-López P; Osman K; Cham M; Narula J; Fuster V; Sanz J
Heart; 2014 Nov; 100(21):1688-95. PubMed ID: 25012950
[TBL] [Abstract][Full Text] [Related]
19. The value of cardiac MRI versus echocardiography in the pre-operative assessment of patients with Duchenne muscular dystrophy.
Brunklaus A; Parish E; Muntoni F; Scuplak S; Tucker SK; Fenton M; Hughes ML; Manzur AY
Eur J Paediatr Neurol; 2015 Jul; 19(4):395-401. PubMed ID: 25843299
[TBL] [Abstract][Full Text] [Related]
20. Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR).
Vöhringer M; Mahrholdt H; Yilmaz A; Sechtem U
Herz; 2007 Mar; 32(2):129-37. PubMed ID: 17401755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
